📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Ancora Pharma

1.1 - Company Overview

Ancora Pharma Logo

Ancora Pharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of immune system modulation therapeutics using synthetic carbohydrates in the United States, offering vaccines against bacterial, parasitic, and viral infectious diseases, as well as therapeutics to treat cardiovascular and metabolic diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Ancora Pharma

RhoVac Logo

RhoVac

HQ: Denmark Website
  • Description: Provider of an immuno-oncology therapeutic cancer vaccine targeting metastatic cancer cells by recognizing RhoC-overexpressing cells to stimulate an immune response (RV001, in clinical trials), plus oncology technologies: iCIP (LiPlaCis + DRP to identify cisplatin responders and deliver the drug with higher efficacy and less toxicity), LiPlaCis (liposomal cisplatin), and DRP (mRNA-based predictor of cisplatin response).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RhoVac company profile →
Numab Therapeutics Logo

Numab Therapeutics

HQ: Switzerland Website
  • Description: Provider of antibody-based therapeutics for severe diseases, including chronic inflammation and cancer, leveraging a plug-and-play platform to predictably yield ready-to-develop multispecific biotherapeutics. Offerings include NM26 for atopic dermatitis, NM49 for cancer, and λ-Cap (stable human antibody fragments) and MATCH (modular scaffolding for multispecific formats) technologies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Numab Therapeutics company profile →
Adheron Therapeutics Logo

Adheron Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology therapeutics that disrupt cell adhesion to treat a variety of diseases, based on pioneering work from Dr. Michael Brenner’s lab at Brigham and Women’s Hospital and Harvard Medical School, including work around Cadherin-11 (Cad-11), a cellular adhesive.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Adheron Therapeutics company profile →
NewAmsterdam Pharma Logo

NewAmsterdam Pharma

HQ: The Netherlands Website
  • Description: Provider of clinical-stage research and development of therapies for cardio-metabolic diseases, including obicetrapib, a selective cholesteryl ester transfer protein (CETP) inhibitor that reduces LDL-C and increases HDL-C for treating metabolic diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NewAmsterdam Pharma company profile →
Abcuro Logo

Abcuro

HQ: United States Website
  • Description: Provider of immunotherapies for autoimmunity and cancer, including ABC008, a monoclonal antibody targeting KLRG1 to selectively deplete highly cytotoxic T cells in inclusion body myositis, T-cell large granular lymphocytic leukemia, and certain cancers, and ABC015, a preclinical antibody blocking KLRG1-ligand interaction to activate cytotoxic T and NK cells; conducts clinical trials for ABC008 in IBM and T-LGLL.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Abcuro company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Ancora Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Ancora Pharma

2.2 - Growth funds investing in similar companies to Ancora Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Ancora Pharma

4.2 - Public trading comparable groups for Ancora Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Ancora Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Ancora Pharma

What does Ancora Pharma do?

Ancora Pharma is a provider of immune system modulation therapeutics using synthetic carbohydrates in the United States, offering vaccines against bacterial, parasitic, and viral infectious diseases, as well as therapeutics to treat cardiovascular and metabolic diseases.

Who are Ancora Pharma's competitors?

Ancora Pharma's competitors and similar companies include RhoVac, Numab Therapeutics, Adheron Therapeutics, NewAmsterdam Pharma, and Abcuro.

Where is Ancora Pharma headquartered?

Ancora Pharma is headquartered in United States.

How many employees does Ancora Pharma have?

Ancora Pharma has 1,000 employees 🔒.

When was Ancora Pharma founded?

Ancora Pharma was founded in 2010 🔒.

What sector and industry vertical is Ancora Pharma in?

Ancora Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Ancora Pharma

Who are the top strategic acquirers in Ancora Pharma's sector and industry

Top strategic M&A buyers and acquirers in Ancora Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Ancora Pharma?

Top strategic M&A buyers groups and sectors for Ancora Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Ancora Pharma's sector and industry vertical

Which are the top PE firms investing in Ancora Pharma's sector and industry vertical?

Top PE firms investing in Ancora Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Ancora Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Ancora Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Ancora Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Ancora Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Ancora Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Ancora Pharma?

The key public trading comparables and valuation benchmarks for Ancora Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Ancora Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Ancora Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Ancora Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Ancora Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Ancora Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Ancora Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Ancora Pharma